EUVIMEDEUVIMED entdecken
Open Access

Investigation of MicroRNA-30d-5p Expression and SOCS3 Levels in Non-small Cell Lung Cancer

Seha Akduman, Sibel Arinç, Müge Kopuz Álvarez Noval, Selvi Duman Bakirezer, Huseyin Kilili, Seda Güleç Yilmaz

In Vivo · 2025

DOI: 10.21873/invivo.14106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2025. Verfasst von Seha Akduman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chest Diseases, Faculty of Medicine, Yeditepe University Hospital, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Suppressor of Cytokine Signaling 3 Protein, MicroRNAs, Gene Expression Regulation, Neoplastic. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Non-small cell lung cancer (NSCLC) accounts for most lung cancer cases and has high mortality, especially in advanced stages. MicroRNAs (miRNAs) and immunoregulatory genes such as suppressor of cytokine signaling 3 (SOCS3) play critical roles in cancer progression and immune evasion. miR-30d-5p is known to act as a tumor suppressor by down-regulating oncogenic pathways, while SOCS3 modulates immune responses and tumor microenvironment interactions. This study aimed to evaluate the clinical relevance of circulating miR-30d-5p and serum SOCS3 protein levels in patients with NSCLC versus healthy controls and to assess their potential as diagnostic and prognostic biomarkers. MATERIALS AND METHODS: Serum samples were collected from 35 patients with NSCLC and 26 healthy individuals. miR-30d-5p expression was measured using RT-qPCR, and SOCS3 protein levels were determined using ELISA. Statistical comparisons were performed, and diagnostic performance was evaluated using Receiver Operating Characteristic (ROC) analysis. The correlation between SOCS3 and miR-30d-5p was assessed with Spearman's rank test. RESULTS: SOCS3 levels were significantly elevated in patients with NSCLC (120.84±117.62 pg/ml) compared to controls (16.88±11.91 pg/ml, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungSuppressor of Cytokine Signaling 3 ProteinMicroRNAsGene Expression Regulation, NeoplasticLung NeoplasmsHumansFemaleMaleMiddle AgedBiomarkers, TumorROC CurveAgedPrognosisCase-Control StudiesNeoplasm StagingAdult

Stichwörter der Autor:innen

JAK/STATNon-small cell lung cancerSOCS3miR-30d-5p

Substanzen

Suppressor of Cytokine Signaling 3 ProteinMicroRNAsSOCS3 protein, humanBiomarkers, TumorMIRN30b microRNA, human

Autor:innen und Institutionen

  • Department of Chest Diseases, Faculty of Medicine, Yeditepe University Hospital, Istanbul, Türkiye.
  • Department of Clinic of Chest Diseases, University of Health Sciences, S.B.Ü. Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Türkiye.
  • Department of Biochemistry, Faculty of Medicine, Yeditepe University, Istanbul, Türkiye.
  • Department of Basic Medical Sciences, Faculty of Medicine, Yeditepe University, Istanbul, Türkiye.
  • Milner Centre for Evolution, Department of Life Sciences, University of Bath, Bath, U.K.
  • BioClavis, LTD, Carus House, Glasgow, U.K.

Zitieren

APA

Akduman, S., Arinç, S., Noval, M. K. Á., Bakirezer, S. D., Kilili, H., & Yilmaz, S. G. (2025). Investigation of MicroRNA-30d-5p Expression and SOCS3 Levels in Non-small Cell Lung Cancer. In Vivo. https://doi.org/10.21873/invivo.14106

Vancouver

Akduman S, Arinç S, Noval MKÁ, Bakirezer SD, Kilili H, Yilmaz SG. Investigation of MicroRNA-30d-5p Expression and SOCS3 Levels in Non-small Cell Lung Cancer. In Vivo. 2025. doi:10.21873/invivo.14106

BibTeX
@article{Akduman2025,
  author = {Akduman, Seha and Arinç, Sibel and Noval, Müge Kopuz Álvarez and Bakirezer, Selvi Duman and Kilili, Huseyin and Yilmaz, Seda Güleç},
  title = {Investigation of MicroRNA-30d-5p Expression and SOCS3 Levels in Non-small Cell Lung Cancer},
  journal = {In Vivo},
  year = {2025},
  doi = {10.21873/invivo.14106}
}
Kostenlos starten →